United States · Bill · S
S. 2026 (109th)
Medicare Prescription Drug Gap Disclosure Act
Introduced
16 November 2005
Last action
—
Status
Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S12959)
Sponsors
—
Subjects
Discovery layer
Source updated
15 August 2025
Summary
Medicare Prescription Drug Gap Disclosure Act - Amends title XVIII (Medicare) of the Social Security Act to require that a prescription drug plan or a Medicare Advantage Prescription Drug Plan with an initial coverage limit obtain a signed certification by an enrollee (or legal guardian), before enrolling, that acknowledges that: (1) a gap in coverage during a given year might occur; and (2) the enrollee, in such a case, will be responsible for paying 100% of the cost of his or her prescription drugs, in addition to the plan's monthly premium.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate (text)
Introduced in Senate · EN · 16 November 2005
Introduced in Senate (PDF)
Introduced in Senate · EN · 16 November 2005
Introduced in Senate
summary · EN · 16 November 2005
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/109th-congress/senate-bill/2026
- Open data entity: https://api.congress.gov/v3/bill/109/s/2026